Hi Khaled,

Previously Mats Karlsson suggested a model for autoinduction for a
compound using a hypothetical enzyme compartment. I have used that for
various types of dosing regimens. You could adapt this into
autoinhibition of metabolite formation.

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&Te
rmToSearch=10594468&ordinalpos=3&itool=EntrezSystem2.PEntrez.Pubmed.Pubm
ed_ResultsPanel.Pubmed_RVDocSum

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&Te
rmToSearch=10848719&ordinalpos=6&itool=EntrezSystem2.PEntrez.Pubmed.Pubm
ed_ResultsPanel.Pubmed_RVDocSum

Plotting A(1), A(2) and A(3) will show how these compartments work. The
enzyme compartment needs to be initialized with an AMT of 1 in the
dataset for each ID. I have suggested some code below for 1-comp parent,
1-comp metabolite without absorption and complete transformation from
parent to metabolite. No doubt you can expand this to your desired
2-comp model.
 
$SUBROUTINES ADVAN6 TOL=3
$MODEL COMP=(CENTRAL) COMP=(ENZ) COMP=(METAB)
$DES
CM=A(3)/V3
DADT(1)=-(K13*A(2))*A(1)                                ;;parent conc
DADT(2)=KENZ-KENZ*A(2)*(1+(CM/(CM+IC50))) ;; hypothetical enzyme
DADT(3)=K13*A(1)-K30*A(3)                       ;; metabolite conc

With friendly regards,
Thomas


Thomas Kerbusch, PhD
Section Head PK-PD
Dept. CPK
N.V. Organon - XW 3133
PO Box 20
5340 BH  Oss
The Netherlands
tel:  +31 412 661621
cell: +31 613045046 (intern 4936)
fax:  +31 412 662542
[EMAIL PROTECTED]  
-----Original Message-----
From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED]
On Behalf Of Khaled Mohammed Abduljalil
Sent: Friday, 22 June, 2007 12:50
To: [email protected]
Subject: [NMusers] autoinhibition

Dear nmusers,

Could anyone support me with nonmem code for a drug undergoes in vivo
hepatic metabolism leading to formation of a metabolite. This metabolite
has the ability to inactivate parent drug transformation. Both parent
and metabolite data can be fitted with a single model of
two-compartment.

thanks in advance

khaled

This message, including attachments, is confidential and may be privileged. If 
you are not an intended recipient, please notify the sender then delete and 
destroy the original message and all copies. You should not copy, forward 
and/or disclose this message, in whole or in part, without permission of the 
sender.

Reply via email to